Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about LIMN, unsubscribe in one click. Privacy
Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.
LIMN holds $3M in cash and short-term investments (as of Jun 30, 2026) and burns about $1.5M/quarter from operations, an estimated runway of 6.1 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 63 · High
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern , management has concluded that there is substantial doubt about its ability to continue as a going concern for one…10-Q, Aug 2026
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LIMN files for a raise →
| Holder | Type | Shares | % of shares | As of |
|---|---|---|---|---|
| Iris Acquisition Holdings LLC 10% owner |
Insider | 6,900,000 | 10.27% | 2025-04-30 |
| Chris Kim Chief Executive Officer, Director, 10% o |
Insider | 6,169,406 | 9.19% | 2025-04-30 |
| Ewon Comfortech Co., Ltd. 10% owner |
Insider | 5,500,000 | 8.19% | 2026-06-24 |
| Valetudo Therapeutics LLC 10% owner · +48,975 options |
Insider | 5,244,351 | 7.81% | 2026-07-02 |
| KH Feelux Co., Ltd 10% owner |
Insider | 4,000,000 | 5.96% | 2025-04-30 |
| Samda Biolab Co., Ltd. | 5%+ holder (13G) | 3,426,548 | 5.10% | 2026-07-02 |
Share count 67,160,362 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LIMN and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →